https://www.zacks.com/stock/news/2246890/clean-harbors-clh-snaps-up-hepaco-for-400-million-cash?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2246890
Mar 27, 2024 - Clean Harbors (CLH) anticipates that HEPACO will contribute around $30 million in Adjusted EBITDA for 2024.
zc:8418022713598187470
0
https://www.zacks.com/stock/news/2246878/sl-green-slg-is-up-4-79-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2246878
Mar 27, 2024 - Does SL Green (SLG) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:6071335023363364864
0
https://www.zacks.com/stock/news/2246775/ups-stock-declines-despite-upbeat-2026-targets-here-s-why?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2246775
Mar 27, 2024 - UPS expects consolidated revenues for 2024 in the $92-$94.5 billion range.
zc:8251059056830565619
0
https://www.zacks.com/stock/news/2246750/ciena-cien-toshiba-team-up-for-quantum-safe-technology?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2246750
Mar 27, 2024 - Ciena (CIEN) and Toshiba partner to showcase quantum secure communication platform at OFC Conference 2024.
zc:6968171762656075123
0
https://www.rttnews.com/story.aspx?Id=3435230
Mar 27, 2024 - iBio, Inc. (IBIO) Wednesday announced partnership with AstralBio, Inc. to develop novel antibodies to treat obesity and other cardiometabolic conditions. iBio shares were up more than 84 percent in premarket at $2.12.
0
rttnews:7075821605564231664
0
https://www.rttnews.com/3435212/german-property-lenders-expect-new-real-estate-financing-to-pick-up-slightly-in-2024.aspx?type=alleco
Mar 27, 2024 - New real estate financing in Germany is set to pick up modestly this year after a massive fall last year amid the worst property market downturn in decades, data from the banking association vdp showed Wednesday. Financing for the construction and acquisition of residential and commercial properties sank 31.3 percent in 2023 to total EUR 110.0 billion, the vdp said.
0
rttnews:7085637205676570394
0
https://seekingalpha.com/news/4083862-morgan-stanley-ups-invivyd-to-overweight-cites-fda-eua-decision?source=feed_sector_healthcare
Mar 26, 2024 - Morgan Stanley upgraded Invivyd (IVVD) to overweight, citing a recent FDA decision to grant emergency use authorization for the company’s prophylactic COVID-19 drug Pemgarda.
0
sa:7348252736351776933
0
https://www.zacks.com/stock/news/2246228/tree-com-tree-is-up-8-94-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2246228
Mar 26, 2024 - Does Tree.com (TREE) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-7109941290519587232
0
https://www.zacks.com/stock/news/2246231/godaddy-gddy-is-up-3-78-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2246231
Mar 26, 2024 - Does GoDaddy (GDDY) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-7643782255878206408
0
https://seekingalpha.com/news/4083198-biotech-roundtable-is-crispr-all-its-cracked-up-to-be?source=feed_sector_healthcare
Mar 26, 2024 - Is CRISPR overhyped? Which companies should investors be paying attention in this emerging field of drug development? Read more here.
0
sa:-6337655756466433499
0